Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
Status:
Withdrawn
Trial end date:
2020-05-18
Target enrollment:
Participant gender:
Summary
This study is designed to assess the safety and exploratory efficacy of using HSC835 in
patients with Inherited Metabolic Disorders (IMD) undergoing stem cell transplantation.